Company Filing History:
1 out of 250 
1 out of 5,309 
1 out of 3 Years Active: 2015
Title: Patrick Sutphin: Innovator in Synthetic Lethal Targeting
Introduction
Patrick Sutphin is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of cancer research. His innovative approach focuses on targeting glucose transport mechanisms to inhibit the growth of specific cancer cells.
Latest Patents
Patrick holds 1 patent for his invention titled "Synthetic lethal targeting of glucose transport." This patent provides methods for inhibiting the growth and proliferation of HIF pathway proficient cells by administering GLUT1 inhibitors. This groundbreaking work has the potential to advance therapeutic strategies in cancer treatment.
Career Highlights
Throughout his career, Patrick has worked with notable organizations, including Auckland Uniservices Limited and Leland Stanford Junior University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant research initiatives.
Collaborations
Patrick has collaborated with esteemed colleagues such as John Irwin and Denise Chan. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Patrick Sutphin is a notable inventor whose work in synthetic lethal targeting has the potential to transform cancer treatment. His innovative methods and collaborations highlight his commitment to advancing medical science.